ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - BIT:1ABBV - US00287Y1091 - Common Stock
194.8 EUR
-6.2 (-3.08%)
We assign a fundamental rating of 5 out of 10 to 1ABBV. 1ABBV was compared to 76 industry peers in the Biotechnology industry. There are concerns on the financial health of 1ABBV while its profitability can be described as average. 1ABBV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 1ABBV was profitable.
1ABBV had a positive operating cash flow in the past year.
Each year in the past 5 years 1ABBV has been profitable.
Each year in the past 5 years 1ABBV had a positive operating cash flow.
1.2 Ratios
The Return On Assets of 1ABBV (2.71%) is better than 76.62% of its industry peers.
With an excellent Return On Invested Capital value of 13.81%, 1ABBV belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ABBV is in line with the industry average of 12.82%.
The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(13.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROIC | 13.81% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
The Profit Margin of 1ABBV (6.38%) is better than 80.52% of its industry peers.
1ABBV's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 31.27%, 1ABBV belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
1ABBV's Operating Margin has declined in the last couple of years.
1ABBV has a better Gross Margin (70.93%) than 64.94% of its industry peers.
1ABBV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ABBV is creating some value.
Compared to 1 year ago, 1ABBV has about the same amount of shares outstanding.
1ABBV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1ABBV is higher compared to a year ago.
2.2 Solvency
1ABBV has an Altman-Z score of 2.40. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 1ABBV (2.40) is better than 63.64% of its industry peers.
1ABBV has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as 1ABBV would need 3.86 years to pay back of all of its debts.
The Debt to FCF ratio of 1ABBV (3.86) is better than 79.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 2.4 |
ROIC/WACC1.52
WACC9.09%
2.3 Liquidity
1ABBV has a Current Ratio of 0.74. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
1ABBV's Current ratio of 0.74 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 76.62% of its industry peers.
A Quick Ratio of 0.61 indicates that 1ABBV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.61, 1ABBV is doing worse than 77.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
1ABBV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.03%.
The Earnings Per Share has been growing slightly by 2.51% on average over the past years.
Looking at the last year, 1ABBV shows a small growth in Revenue. The Revenue has grown by 6.05% in the last year.
The Revenue has been growing by 11.11% on average over the past years. This is quite good.
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
3.2 Future
The Earnings Per Share is expected to grow by 13.59% on average over the next years. This is quite good.
1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.22% yearly.
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.36, the valuation of 1ABBV can be described as rather expensive.
1ABBV's Price/Earnings ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 80.52% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1ABBV to the average of the S&P500 Index (25.83), we can say 1ABBV is valued inline with the index average.
The Price/Forward Earnings ratio is 15.55, which indicates a correct valuation of 1ABBV.
1ABBV's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 87.01% of the companies in the same industry.
1ABBV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 32.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.36 | ||
| Fwd PE | 15.55 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 77.92% of the companies listed in the same industry.
1ABBV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 84.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.91 | ||
| EV/EBITDA | 17.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ABBV does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1ABBV may justify a higher PE ratio.
1ABBV's earnings are expected to grow with 16.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.45
PEG (5Y)8.51
EPS Next 2Y19.88%
EPS Next 3Y16.85%
5. Dividend
5.1 Amount
1ABBV has a Yearly Dividend Yield of 2.87%.
Compared to an average industry Dividend Yield of 11.19, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 94.81% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, 1ABBV pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
5.2 History
On average, the dividend of 1ABBV grows each year by 7.72%, which is quite nice.
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1ABBV pays out 304.54% of its income as dividend. This is not a sustainable payout ratio.
1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP304.54%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
BIT:1ABBV (10/15/2025, 7:00:00 PM)
194.8
-6.2 (-3.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners74.42%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap344.13B
Revenue(TTM)58.33B
Net Income(TTM)3.72B
Analysts79.46
Price Target197.82 (1.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
Yearly Dividend5.38
Dividend Growth(5Y)7.72%
DP304.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.04%
Min EPS beat(2)0.95%
Max EPS beat(2)1.14%
EPS beat(4)4
Avg EPS beat(4)0.75%
Min EPS beat(4)0.02%
Max EPS beat(4)1.14%
EPS beat(8)7
Avg EPS beat(8)0.76%
EPS beat(12)9
Avg EPS beat(12)0.46%
EPS beat(16)11
Avg EPS beat(16)0.4%
Revenue beat(2)2
Avg Revenue beat(2)0.93%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.23%
Revenue beat(4)2
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)5
Avg Revenue beat(12)-0.32%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)4.92%
PT rev (3m)5.18%
EPS NQ rev (1m)-45.1%
EPS NQ rev (3m)-44.14%
EPS NY rev (1m)-12.38%
EPS NY rev (3m)-13.98%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.36 | ||
| Fwd PE | 15.55 | ||
| P/S | 6.85 | ||
| P/FCF | 21.91 | ||
| P/OCF | 20.72 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.28 |
EPS(TTM)9.12
EY4.68%
EPS(NY)12.52
Fwd EY6.43%
FCF(TTM)8.89
FCFY4.56%
OCF(TTM)9.4
OCFY4.83%
SpS28.43
BVpS-0.09
TBVpS-45.26
PEG (NY)3.45
PEG (5Y)8.51
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROCE | 18.72% | ||
| ROIC | 13.81% | ||
| ROICexc | 14.74% | ||
| ROICexgc | 370.81% | ||
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% | ||
| FCFM | 31.27% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 12.62% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.74% | ||
| Profit Quality | 489.9% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 2.4 |
F-Score6
WACC9.09%
ROIC/WACC1.52
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
EBIT growth 1Y13.81%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year20.95%
EBIT Next 3Y15.22%
EBIT Next 5Y11.27%
FCF growth 1Y-26.45%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-24.5%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
Can you provide the valuation status for ABBVIE INC?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for 1ABBV stock?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 21.36 and the Price/Book (PB) ratio is -2183.6.
Can you provide the financial health for 1ABBV stock?
The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.